NL300105I2 - Nieuwe selectieve remstoffen van virale of bacteriële neuraminidasen. - Google Patents

Nieuwe selectieve remstoffen van virale of bacteriële neuraminidasen.

Info

Publication number
NL300105I2
NL300105I2 NL300105C NL300105C NL300105I2 NL 300105 I2 NL300105 I2 NL 300105I2 NL 300105 C NL300105 C NL 300105C NL 300105 C NL300105 C NL 300105C NL 300105 I2 NL300105 I2 NL 300105I2
Authority
NL
Netherlands
Prior art keywords
viral
selective inhibitors
neuraminidase
compounds
new selective
Prior art date
Application number
NL300105C
Other languages
English (en)
Other versions
NL300105I1 (nl
Original Assignee
Gilead Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27410155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300105(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/476,946 external-priority patent/US5866601A/en
Application filed by Gilead Sciences filed Critical Gilead Sciences
Publication of NL300105I1 publication Critical patent/NL300105I1/nl
Publication of NL300105I2 publication Critical patent/NL300105I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Pyrane Compounds (AREA)
NL300105C 1995-02-27 2002-10-29 Nieuwe selectieve remstoffen van virale of bacteriële neuraminidasen. NL300105I2 (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39524595A 1995-02-27 1995-02-27
US08/476,946 US5866601A (en) 1995-02-27 1995-06-06 Carbocyclic compounds
US58056795A 1995-12-29 1995-12-29
PCT/US1996/002882 WO1996026933A1 (en) 1995-02-27 1996-02-26 Novel selective inhibitors of viral or bacterial neuraminidases

Publications (2)

Publication Number Publication Date
NL300105I1 NL300105I1 (nl) 2003-01-06
NL300105I2 true NL300105I2 (nl) 2003-02-03

Family

ID=27410155

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300105C NL300105I2 (nl) 1995-02-27 2002-10-29 Nieuwe selectieve remstoffen van virale of bacteriële neuraminidasen.

Country Status (27)

Country Link
US (3) US5952375A (nl)
EP (1) EP0759917B1 (nl)
JP (3) JP3300365B2 (nl)
KR (1) KR100447096B1 (nl)
CN (2) CN1185223C (nl)
AT (2) ATE191711T1 (nl)
AU (1) AU720933B2 (nl)
BR (2) BR9607098B8 (nl)
CZ (1) CZ297945B6 (nl)
DE (4) DE10299052I1 (nl)
DK (1) DK0759917T3 (nl)
ES (2) ES2249863T3 (nl)
GR (1) GR3033914T3 (nl)
HK (1) HK1026893A1 (nl)
HU (1) HU228450B1 (nl)
LU (1) LU90991I2 (nl)
MX (1) MX9706496A (nl)
NL (1) NL300105I2 (nl)
NO (1) NO318455B1 (nl)
NZ (1) NZ306625A (nl)
PL (1) PL194173B1 (nl)
PT (1) PT759917E (nl)
RU (1) RU2181357C2 (nl)
SG (1) SG45864A1 (nl)
SI (1) SI9620042A (nl)
UA (1) UA56128C2 (nl)
WO (1) WO1996026933A1 (nl)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9620042A (sl) * 1995-02-27 1998-12-31 Gilead Sciences, Inc. Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
EP0920410B1 (en) * 1996-08-23 2002-03-27 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
CN1238762A (zh) * 1996-10-21 1999-12-15 吉里德科学公司 哌啶化合物
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
AU732916C (en) * 1996-11-14 2002-06-06 Biota Scientific Management Pty Ltd Method and novel compounds for use therein
AU8673598A (en) * 1997-08-01 1999-02-22 University Of Florida Neuraminidase inhibitors
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
IL134691A0 (en) * 1997-09-17 2001-04-30 Gilead Sciences Inc Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
CN1282316A (zh) * 1997-12-17 2001-01-31 生物晶体药品股份有限公司 用作神经氨酸酶抑制剂的取代环戊烷和环戊烯化合物
CN1328546A (zh) * 1998-04-23 2001-12-26 艾博特公司 作为神经氨酸酶抑制剂的吡咯烷
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
DE69900483T2 (de) * 1998-05-13 2002-06-27 Hoffmann La Roche Verfahren zur Herstellung von Shikiminsäure und deren Derivate
AU1476900A (en) * 1998-11-13 2000-06-05 Gilead Sciences, Inc. 1,4,5,6-tetrahydro-pyridazine derivatives, their preparation and their use as neuraminidase inhibitors
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
DE60002949T2 (de) * 1999-06-11 2004-05-19 F. Hoffmann-La Roche Ag Verfahren zur Herstellung des Neuraminidase-Inhibitoren ro-64-0796
DE19930177B4 (de) 1999-06-30 2007-02-08 Nikolai Vladimirovich Bovin Intermolekular assoziierende Verbindungen und deren Verwendung
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
WO2001028981A1 (en) * 1999-10-19 2001-04-26 Abbott Laboratories 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors
US6627396B1 (en) * 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
JP2001131144A (ja) * 1999-11-02 2001-05-15 Sagami Chem Res Center ７−アザビシクロ［４．１．０］ヘプト−３−エン−３−カルボン酸エステル類の製造方法
US6462226B1 (en) * 1999-12-03 2002-10-08 Hoffmann-La Roche Inc. Process for the preparation of 4,5-diamino shikimic acid derivatives
CN1184216C (zh) 1999-12-27 2005-01-12 财团法人相模中央化学研究所 制备5－氧代－7－氧杂双环[4.1.0]庚－3－烯－3－羧酸酯的方法
US8642051B2 (en) * 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
JP4149803B2 (ja) 2000-06-27 2008-09-17 エフ．ホフマン−ラ ロシュ アーゲー 組成物の調製方法
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002092555A1 (fr) * 2001-05-11 2002-11-21 Sankyo Company, Limited Derives d'acides sialiques
US6964784B2 (en) * 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
NZ543864A (en) 2003-06-16 2009-10-30 Leuven K U Res & Dev Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
WO2007053792A2 (en) * 2005-11-05 2007-05-10 Amplyx Pharmaceuticals, Inc. Improving the pharmacokinetics of protease inhibitors and other drugs
ATE510813T1 (de) * 2005-11-25 2011-06-15 Hetero Drugs Ltd Verbessertes verfahren für oseltamivirphosphat
KR100819759B1 (ko) 2005-12-01 2008-04-07 (주)파인켐 아자이드 화합물의 폭발성을 제거한 공정을 이용한 1,2-다이아미노 화합물 또는 이의 부가염 제조 방법
EP2178819A2 (en) * 2005-12-28 2010-04-28 F.Hoffmann-La Roche Ag Epoxide intermediate in the tamiflu synthesis
BRPI0708108B1 (pt) 2006-02-20 2021-12-14 Chugai Seiyaku Kabushiki Kaisha Composição farmacêutica compreendendo fosfato de oseltamivir
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US20080306098A1 (en) * 2006-11-06 2008-12-11 Mutz Mitchell W Pharmacokinetics of protease inhibitors and other drugs
JP5345073B2 (ja) 2007-01-23 2013-11-20 テラピコン エス．アール．エル． 抗ウイルス化合物
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US8435769B2 (en) * 2007-04-13 2013-05-07 Monsanto Technology Llc Use of glyphosate to produce shikimic acid in microorganisms
US20090054334A1 (en) * 2007-05-23 2009-02-26 Mutz Mitchell W Combinatorial improvement of bifunctional drug properties
US7888337B2 (en) 2007-08-31 2011-02-15 Academia Sinica Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
US8344178B2 (en) 2007-10-16 2013-01-01 Monsanto Technology Llc Processes for producing and recovering shikimic acid
WO2009055042A1 (en) * 2007-10-24 2009-04-30 Amplyx Pharmaceuticals, Inc. Enhancing the efficacy of anti-infective therapeutics
US8304553B2 (en) * 2007-12-19 2012-11-06 Nanyang Technological University Method of forming oseltamivir and derivatives thereof
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
US20100081713A1 (en) * 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
US20120058937A9 (en) 2008-04-15 2012-03-08 Tsrl, Inc. Prodrugs of Neuraminidase Inhibitors
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
CN101486664B (zh) * 2008-12-31 2013-09-04 北京大学深圳研究生院 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物
CA2762022A1 (en) 2009-05-15 2010-11-18 Redx Pharma Limited Redox drug derivatives
WO2011021223A2 (en) * 2009-08-19 2011-02-24 Msn Laboratories Limited Novel salts of ethyl (3r, 4s, 5r)-4,5-imino-3-(l-ethylpropoxy)-1- cvclohexene-1-carboxylate and its use
JP5837502B2 (ja) * 2009-11-11 2015-12-24 スリーエム イノベイティブ プロパティズ カンパニー ポリマー組成物並びにその製造方法及び物品
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
CN103189354A (zh) 2010-07-16 2013-07-03 格林代克斯联合股份公司 具有抗病毒功效的1,4-二氢吡啶衍生物
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
EP2578218A1 (en) 2011-10-06 2013-04-10 Grindeks, A Joint Stock Company Antiviral efficacy of disodium 2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) and its derivatives
DE102011117128A1 (de) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2489422C1 (ru) * 2012-05-12 2013-08-10 Александр Васильевич Иващенко Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси)циклогексен-1-карбоновые кислоты, их эфиры и способ применения
RU2521593C1 (ru) * 2013-02-27 2014-06-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Моно и дифторзамещенные этил (3r,4r,5s)-5-азидо-4-ацетиламино-3-(1-этилпропокси)-циклогексен-1-карбоксилаты, способ получения и применения
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
CN103819357B (zh) * 2014-01-28 2016-03-16 浙江大学 (-)-有效霉醇叠氮四乙酸酯的制备方法
JP6501074B2 (ja) * 2014-02-14 2019-04-17 トーアエイヨー株式会社 環状炭化水素化合物
MX2016014859A (es) 2014-05-12 2017-06-27 Glaxosmithkline Intellectual Property (No 2) Ltd Composiciones farmaceuticas que comprenden danirixina para tratar enfermedades infecciosas.
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
GB2532178A (en) * 2014-06-09 2016-05-18 Redx Pharma Plc Antiviral compounds
KR20230130175A (ko) 2014-12-26 2023-09-11 에모리 유니버시티 Ｎ4-하이드록시시티딘, 이와 관련된 유도체 및 이의 항 바이러스적 용도
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
WO2017106820A1 (en) * 2015-12-17 2017-06-22 Thomas Jefferson University Antiviral agents for drug-resistant influenza a
KR102339817B1 (ko) 2016-06-30 2021-12-16 한미약품 주식회사 오셀타미비어 함유 경구용 고형제제 및 그 제조방법
JP6249434B1 (ja) * 2016-08-10 2017-12-20 塩野義製薬株式会社 置換された多環性ピリドン誘導体およびそのプロドラッグを含有する医薬組成物
EP3706762A4 (en) 2017-12-07 2021-09-01 Emory University N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTIVIRAL USES IN RELATION TO IT
KR20200106607A (ko) 2019-03-05 2020-09-15 주식회사 코아팜바이오 오셀타미비르 함유 의약 조성물

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968788A (en) * 1986-04-04 1990-11-06 Board Of Regents, The University Of Texas System Biologically reversible phosphate and phosphonate protective gruops
US5206400A (en) * 1986-07-07 1993-04-27 Ohio State University Diastereomeric mono- and di-substituted diamino cyclohexane compounds and the method of preparation thereof
US5175273A (en) * 1988-07-01 1992-12-29 Genentech, Inc. Nucleic acid intercalating agents
US5270340A (en) * 1988-12-27 1993-12-14 Bayer Aktiengesellschaft Substituted 2-cyclohexen-1-yl-amine fungicidal and herbicidal agents
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
DE4033415A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Antimikrobielle mittel sowie substituierte 2-cyclohexan-1-yl-amin-derivate und deren herstellung
DE4131311A1 (de) * 1991-09-20 1993-04-01 Basf Ag Dihydropyranderivate und diese enthaltende pflanzenschutzmittel
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5292938A (en) * 1992-04-13 1994-03-08 Associated Universities, Inc. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging
US5633360A (en) 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
US5639786A (en) * 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
US5514798A (en) * 1993-06-02 1996-05-07 Gilead Sciences, Inc. Method and cyclic carbonates for nucleotide analogues
GB9311873D0 (en) * 1993-06-09 1993-07-28 Glaxo Group Ltd Process
GB9311892D0 (en) * 1993-06-09 1993-07-28 Glaxo Wellcome Australia Ltd Device
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
AU710492B2 (en) 1994-11-04 1999-09-23 Gilead Sciences, Inc. Thiepane compounds inhibiting and detecting HIV protease
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
SI9620042A (sl) * 1995-02-27 1998-12-31 Gilead Sciences, Inc. Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
GB9525389D0 (en) 1995-12-12 1996-02-14 Biota Scient Management Ltd Chemical compounds
GB9510141D0 (en) 1995-05-19 1995-07-12 Biota Scient Management Chemical compounds
CN1184473A (zh) * 1995-05-19 1998-06-10 比奥塔科学管理有限公司 6－羟基酰胺－二氢吡喃衍生物
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
EP0920410B1 (en) 1996-08-23 2002-03-27 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5948816A (en) * 1996-09-10 1999-09-07 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
US5886213A (en) 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds

Also Published As

Publication number Publication date
NO973908L (no) 1997-10-27
JPH11501908A (ja) 1999-02-16
ATE305453T1 (de) 2005-10-15
ES2118674T1 (es) 1998-10-01
US6225341B1 (en) 2001-05-01
NO973908D0 (no) 1997-08-26
UA56128C2 (uk) 2003-05-15
DE69607704D1 (de) 2000-05-18
US20050176758A1 (en) 2005-08-11
JP2006036770A (ja) 2006-02-09
GR3033914T3 (en) 2000-11-30
ES2249863T3 (es) 2006-04-01
NL300105I1 (nl) 2003-01-06
HUP9800026A3 (en) 2002-04-29
US5952375A (en) 1999-09-14
LU90991I2 (fr) 2003-02-11
DE10299052I1 (de) 2003-05-22
WO1996026933A1 (en) 1996-09-06
DE69607704T2 (de) 2000-12-28
CN1347693A (zh) 2002-05-08
RU2181357C2 (ru) 2002-04-20
CN1185223C (zh) 2005-01-19
ES2118674T3 (es) 2000-08-16
HUP9800026A2 (hu) 1999-09-28
PL194173B1 (pl) 2007-05-31
CZ269097A3 (en) 1997-11-12
BR9607098B8 (pt) 2014-11-18
PL322000A1 (en) 1998-01-05
SI9620042A (sl) 1998-12-31
JP2002161074A (ja) 2002-06-04
NZ306625A (en) 2001-04-27
KR19980703600A (ko) 1998-12-05
DE69635231D1 (de) 2006-02-09
HU228450B1 (en) 2013-03-28
NO318455B1 (no) 2005-03-21
AU720933B2 (en) 2000-06-15
AU5357196A (en) 1996-09-18
JP4234917B2 (ja) 2009-03-04
DE759917T1 (de) 1998-10-22
DE69635231T2 (de) 2006-07-13
DK0759917T3 (da) 2000-07-31
CN1147813A (zh) 1997-04-16
JP3300365B2 (ja) 2002-07-08
ATE191711T1 (de) 2000-04-15
KR100447096B1 (ko) 2005-10-11
EP0759917B1 (en) 2000-04-12
EP0759917A1 (en) 1997-03-05
PT759917E (pt) 2000-10-31
HK1026893A1 (en) 2000-12-29
MX9706496A (es) 1997-11-29
SG45864A1 (en) 1999-04-27
CN100409844C (zh) 2008-08-13
BR9607098A (pt) 1997-11-04
CZ297945B6 (cs) 2007-05-02

Similar Documents

Publication Publication Date Title
NL300105I2 (nl) Nieuwe selectieve remstoffen van virale of bacteriële neuraminidasen.
TR200000723T2 (tr) Altı elemanlı halkalar ihtiva eden bileşikler ve ilaç olarak kullanımları.
PT788605E (pt) Deteccao de anticorpos bacterianos por polarizacao de fluorescencia
BR9811039A (pt) Citocina de mamìferos: interleucina-b30 e reagentes relacionados
BR9812783A (pt) "sistemas de detecção para o registro de interações e as relações funcionais de proteìnas"
DE69422687D1 (de) Biosensor zur hämatokritbestimmung
PT922226E (pt) Processo para a avaliacao do estado de um organismo por meio de medicao de peptideos
PT923394E (pt) Sistema de bomba com deteccao de erro para nutricao clinica
CY1108288T1 (el) Αντισωματα για το αντιγονο κυτταρων langerhans θηλαστικων και χρησεις τους
EA199800844A1 (ru) Способ получения r-альфа-пропил-пиперониламина и его аналогов, промежуточные продукты, используемые в этом способе
EP0976734A3 (en) Selective inhibitors of viral or bacterial neuraminidase
FR2799281B1 (fr) Procede et dispositif de detection d'une reaction de reconnaissance moleculaire
WO1999010365A3 (en) 5',5'-linked oligomers having anti-thrombin activity
DE69405989D1 (de) Hippurikasegen
ITRM930038A0 (it) Corredo per analisi microbiologiche mediante coltura.
DE59808864D1 (de) System zur Ermittlung des Nährstoffbedarfes
KR950020303U (ko) 환형 세선 파단시편 단면적 측정지그
UA2743S (uk) Пляшка для токайських вин
BR9603281A (pt) Sistema de inspeção de medição de espessura de chapas de vedação dos gasômetros
ITCN960010A1 (it) Sistema di vibrola per chitarra e strumenti simili.
DE29706725U1 (de) System zur Präsentation von Exemplar-Segmenten